San Diego, CA, United States of America

Godfrey Jonah Anderson Rainey

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Inventor Spotlight: Godfrey Jonah Anderson Rainey**

Introduction

Godfrey Jonah Anderson Rainey is an innovative inventor based in San Diego, California. With a focus on advanced biotechnological solutions, he has made significant contributions to the field through his patent, which targets cancer-related antigens.

Latest Patents

Rainey's notable patent is titled "Human antibodies to Tn antigen." This invention provides compositions that facilitate the production of antibodies or functional fragments specifically aimed at the Tn antigen and sTn antigen. The patent outlines isolated antibodies that bind to these antigens, along with methods for treating or preventing diseases such as cancer and tumor formation. It also includes information on conjugates of the antibodies linked to localizing, detectable, or therapeutic agents, which may enhance the effectiveness of the treatment.

Career Highlights

Currently, Rainey is employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work there emphasizes the development and application of groundbreaking biomedical innovations, particularly in the realm of antibody therapies.

Collaborations

Throughout his career, Rainey has collaborated with other esteemed professionals, including Wolfgang Walter Scholz and Ritsuko Sawada. These partnerships have contributed to advancing research and innovation in biotechnology and therapeutics.

Conclusion

Godfrey Jonah Anderson Rainey's contributions to science and medicine through his patent on human antibodies exemplify the impact of innovation in combating serious diseases like cancer. His work at Boehringer Ingelheim International GmbH and collaborations with other experts further highlight the collaborative effort required to push the boundaries of biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…